COL1A1 and myocardial infarction: In line with this, the impaired expressions of fibrotic markers COL1A1 and α-SMA in shSafe-treated MI hearts were also partially reversed by Sfrp2 overexpression, as indicated by qRT-PCR and western blot results (Figure 6E-F).